Hologic (Nasdaq:HOLX) today announced a new partnership with recently drafted NFL quarterback Kelee Ringo and his mother. The partnership with Ringo and his mother, breast cancer survivor Tralee Hale, aims to provide education around breast health. That includes the importance of prioritizing annual mammograms and other key health screenings. Last month, the Philadelphia Eagles drafted […]
Hologic
Hologic beats The Street in Q2, raises guidance
Hologic today posted second-quarter results that topped the consensus forecast despite dipping COVID-19-related sales. The Marlborough, Massachusetts-based women’s health and diagnostics company posted profits of $218.5 million. That amounts to 87¢ per share on sales of $1.03 billion for the three months ended April 1, 2023. Hologic posted a 52% bottom-line slide on a sales […]
FDA approves BD HPV assay for use with Hologic ThinPrep Pap test
BD (NYSE:BDX) announced today that it received FDA approval for its Onclarity HPV assay for use with the ThinPrep Pap test. The ThinPrep Pap test, developed by Hologic (Nasaq:HOLX), offers Pap and HPV testing from one vial. It accompanies the BD SurePath liquid-based Pap test vial as the most commonly used vials by labs in […]
Hologic NovaSure V5 endometrial ablation device wins European, Canadian approval
Hologic (Nasdaq:HOLX) announced today that Canadian and European officials approved its NovaSure V5 global endometrial ablation (GEA) device. Marlborough, Massachusetts-based Hologic designed the device to treat a wide range of cervical and uterine anatomies. It offers treatment for abnormal uterine bleeding. In a news release, Hologic cites 97% patient satisfaction with NovaSure. The device also […]
5 reasons you should feel good about medtech companies in 2023
“Macroeconomic headwinds” is a phrase repeated a lot these days, but a string of positive medtech company earnings reports this week should cheer medical device industry insiders. The medical device industry may once again prove that it’s an economically resilient space. “While 2022 brought its share of supply chain and inflationary pressures, directionally, many companies […]
Hologic starts the year strongly
Hologic (Nasdaq: HOLX) reported Street-beating first-quarter results, with company officials confident enough to boost full-year revenue and earnings guidance. Revenue from the women’s health and diagnostics company’s COVID-19 assays may be in decline. Plus, there are supply chain challenges related to semiconductor chips in its Breast Health business. Despite the hurdles, sales growth is strong […]
Fresenius Medical Care joins health equity pledge
Fresenius Medical Care announced today that it joined the Zero Health Gaps Pledge at the World Economic Forum in Davos, Switzerland. As part of the Global Health Equity Network (GHEN), the pledge brings together stakeholders from the public and private sectors. In line with the UN Sustainable Development Goals, they aim to advance a collective […]
Hologic expects Q1 revenues, EPS to top prior guidance
Hologic (Nasdaq:HOLX) today announced preliminary first-quarter revenue results for the three months ended Dec. 31, 2022. Marlborough, Massachusetts–based Hologic expects to report revenues of approximately $1.07 billion. That represents a 27% decrease from the same period of the previous year. However, it comes in above Hologic’s guidance range of $940 million to $990 million set […]
Hologic stock rises on Street-beating Q4 despite continued supply chain challenges
Hologic (Nasdaq:HOLX) shares are up today — a day after fourth-quarter results that came in well ahead of the consensus forecast. Shares of HOLX were up more than 8% at $73.80 apiece by afternoon trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up more than 2%. The […]
These 10 medical device companies have the most revenue per employee
One way to measure medical device companies’ efficiency is to calculate revenue per employee. While compiling corporate data for MassDevice and Medical Design & Outsourcing‘s recent Medtech Big 100 report on the largest medical device companies, we took the companies reporting headcounts. Then, we divided the revenue by the number of workers. When it comes […]
Hologic’s Q3 earnings exceed expectations despite sales slowdown and chip shortage
Hologic (Nasdaq:HOLX) posted third-quarter results today that beat the consensus forecast on Wall Street and increased its outlook for the rest of the year. Marlborough, Massachusetts–based Hologic reported profits of $228.4 million, or $0.90 per share, on sales of $1 billion for the three months ended June 25, 2022. Compared with Q3 2021, profits decreased […]